XELOX doublet regimen versus EOX triplet regimen as first‐line treatment for advanced gastric cancer: An open‐labeled, multicenter, randomized, prospective phase III trial (EXELOX)...

Por Xiao‐Dong Zhu, Ming‐Zhu Huang, Yu‐Sheng Wang, Wan‐Jing Feng, Zhi‐Yu Chen, Yi‐Fu He, Xiao‐Wei Zhang, Xin Liu, Chen‐Chen Wang, Wen Zhang, Jie‐Er Ying, Jun Wu, Lei Yang, Yan‐Ru Qin, Jian‐Feng Luo, Xiao‐Ying Zhao, Wen‐Hua Li, Zhe Zhang, Li‐Xin Qiu, Qi‐Rong Geng, Jian‐Ling Zou, Jie‐Yun Zhang, Hong Zheng, Xue‐Feng Song, Shu‐Sheng Wu, Cheng‐Yan Zhang, Zhe Gong, Qin‐Qin Liu, Xiao‐Feng Wang, Qi Xu, Qi Wang, Jian‐Mei Ji, Jian Zhao, Wei‐Jian Guo
Publicado em 2022-04-01